These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32783992)
1. NHEJ inhibitor SCR7 and its different forms: Promising CRISPR tools for genome engineering. Ray U; Vartak SV; Raghavan SC Gene; 2020 Dec; 763():144997. PubMed ID: 32783992 [TBL] [Abstract][Full Text] [Related]
2. SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end-joining. Manjunath M; Choudhary B; Raghavan SC Cancer Rep (Hoboken); 2021 Jun; 4(3):e1341. PubMed ID: 33496064 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of nonhomologous end joining to increase the specificity of CRISPR/Cas9 genome editing. Vartak SV; Raghavan SC FEBS J; 2015 Nov; 282(22):4289-94. PubMed ID: 26290158 [TBL] [Abstract][Full Text] [Related]
4. Autocyclized and oxidized forms of SCR7 induce cancer cell death by inhibiting nonhomologous DNA end joining in a Ligase IV dependent manner. Vartak SV; Swarup HA; Gopalakrishnan V; Gopinatha VK; Ropars V; Nambiar M; John F; Kothanahally SKS; Kumari R; Kumari N; Ray U; Radha G; Dinesh D; Pandey M; Ananda H; Karki SS; Srivastava M; Charbonnier JB; Choudhary B; Mantelingu K; Raghavan SC FEBS J; 2018 Nov; 285(21):3959-3976. PubMed ID: 30230716 [TBL] [Abstract][Full Text] [Related]
5. SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV. Greco GE; Matsumoto Y; Brooks RC; Lu Z; Lieber MR; Tomkinson AE DNA Repair (Amst); 2016 Jul; 43():18-23. PubMed ID: 27235626 [TBL] [Abstract][Full Text] [Related]
6. Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells. Li G; Zhang X; Zhong C; Mo J; Quan R; Yang J; Liu D; Li Z; Yang H; Wu Z Sci Rep; 2017 Aug; 7(1):8943. PubMed ID: 28827551 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of novel SCR7-based small-molecule inhibitor of DNA end-joining, SCR130 and its relevance in cancer therapeutics. Ray U; Raul SK; Gopinatha VK; Ghosh D; Rangappa KS; Mantelingu K; Raghavan SC Mol Carcinog; 2020 Jun; 59(6):618-628. PubMed ID: 32189406 [TBL] [Abstract][Full Text] [Related]
9. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Maruyama T; Dougan SK; Truttmann MC; Bilate AM; Ingram JR; Ploegh HL Nat Biotechnol; 2015 May; 33(5):538-42. PubMed ID: 25798939 [TBL] [Abstract][Full Text] [Related]
10. SCR7, an inhibitor of NHEJ can sensitize tumor cells to ionization radiation. Gopalakrishnan V; Sharma S; Ray U; Manjunath M; Lakshmanan D; Vartak SV; Gopinatha VK; Srivastava M; Kempegowda M; Choudhary B; Raghavan SC Mol Carcinog; 2021 Sep; 60(9):627-643. PubMed ID: 34192388 [TBL] [Abstract][Full Text] [Related]
11. Bridging Gaps in HDR Improvement: The Role of MAD2L2, SCAI, and SCR7. Anuchina AA; Zaynitdinova MI; Demchenko AG; Evtushenko NA; Lavrov AV; Smirnikhina SA Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047677 [TBL] [Abstract][Full Text] [Related]
12. Modulation of DNA double-strand break repair as a strategy to improve precise genome editing. Ray U; Raghavan SC Oncogene; 2020 Oct; 39(41):6393-6405. PubMed ID: 32884115 [TBL] [Abstract][Full Text] [Related]
13. An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Srivastava M; Nambiar M; Sharma S; Karki SS; Goldsmith G; Hegde M; Kumar S; Pandey M; Singh RK; Ray P; Natarajan R; Kelkar M; De A; Choudhary B; Raghavan SC Cell; 2012 Dec; 151(7):1474-87. PubMed ID: 23260137 [TBL] [Abstract][Full Text] [Related]
15. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in Zhang WW; Matlashewski G mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745 [TBL] [Abstract][Full Text] [Related]
16. Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein. Ma Y; Chen W; Zhang X; Yu L; Dong W; Pan S; Gao S; Huang X; Zhang L RNA Biol; 2016 Jul; 13(7):605-12. PubMed ID: 27163284 [TBL] [Abstract][Full Text] [Related]
17. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Chu VT; Weber T; Wefers B; Wurst W; Sander S; Rajewsky K; Kühn R Nat Biotechnol; 2015 May; 33(5):543-8. PubMed ID: 25803306 [TBL] [Abstract][Full Text] [Related]
18. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells. Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482 [TBL] [Abstract][Full Text] [Related]
19. Pluronic copolymer encapsulated SCR7 as a potential anticancer agent. John F; George J; Srivastava M; Hassan PA; Aswal VK; Karki SS; Raghavan SC Faraday Discuss; 2015; 177():155-61. PubMed ID: 25608025 [TBL] [Abstract][Full Text] [Related]
20. Nuclear domain 'knock-in' screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing. Pinder J; Salsman J; Dellaire G Nucleic Acids Res; 2015 Oct; 43(19):9379-92. PubMed ID: 26429972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]